Markers of endothelial dysfunction in hyperglycaemic Asian Indian subjects

Journal of Diabetes and its Complications

Volumn 18, Issue 1, 2004, Pages 47-52

  Viswanathan, Vijay ^a   Snehalatha, C ^a   Nair, Mamtha B ^a   Ramachandran, A ^a  

^a Diabetes Research Centre Tamil Nadu   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; GLUCOSE; HEMOGLOBIN A1C; INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN; ASSOCIATION; BIOCHEMISTRY; BLOOD VESSEL INJURY; BODY MASS; BODY REGIONS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE MARKER; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INDIAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TIME;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; INDIA; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 1542408909     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(03)00037-0     Document Type: Article

References (37)

1. Bannan S., Mansfield M.W., Grant P.J. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia. 41:1998;460-466.
2. Bertello P., Velligo F., Pinna G., Gurioli L., Molino P., Alban S., Chiandussi L. Plasma endothelin in NIDDM patients with and without complications. Diabetes Care. 17:1994;574-577.
3. Bluher M., Unger R., Rassoul F., Richter V., Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia. 45:2002;210-216.
4. Caballero A.E., Arora S., Saouaf R., Lim S.C., Smakowski P., Park J.Y., King G.L., LoGerfo F.W., Horton E.S., Veves A. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 48:1999;1856-1862.
5. Carlos T., Kovach N., Schwartz B., Rosa M., Newman B., Waynes E., Benjamin C., Osborn L., Lobb R., Harlan J. Human monocytes bend to 2 cytokine-induced adhesive ligands on cultured human EC: endothelial leukocyte adhesion molecule-1 and VCAM-1. Blood. 77:1991;2266-2271.
6. Celermajer D.S., Adams M.R., Clarkson P., Robinson J., McCredie R., Donald A., Deanfield J.E. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. New England Journal of Medicine. 334:1996;150-154.
7. Clausen P., Jacobsen P., Rossing K., Jensen J.S., Parving H.-H., Feldt-Rasmussen B. Plasma concentrations of ICAM-1 and VCAM-1 are elevated in patients with type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabetic Medicine. 17:2000;644-649.
8. Cosentino F., Luscher T.F. Endothelial dysfunction in diabetes mellitus. Journal of Cardiovascular Pharmacology. 32(Suppl. 3):1998;S54-S61.
9. Definition, diagnosis and classification of diabetes mellitus and its complication. Report of consultation. Report 250. Geneva: WHO, 1999.
10. Ferri C., Desideri G., Baldoncini R., Bellini B., De Angelis C., Mazzocchi C., Santucci A. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes. 47:1998;660-667.
11. Foster-Swanson A., Swartzentruber M., Roberts P., Feld R., Johnson M., Wong S., Bartsch J., Dees K., Toner M., Cloyd D., Dacquette J., Wu A., Bradley H., Trundle D. Reference interval studies of the rate-blanked creatinine/Jaffe method on BM/Hitachi systems in six U.S. laboratories. Clin Chem. Vol 40:1057:1994;. Abstract No. 361.
12. Haffner S.M. The importance of hyperglycaemia in the non-fasting state to the development of cardiovascular disease. Endocrine Reviews. 19:1998;583-592.
13. Hlubocka Z., Umnerova V.V., Heller S., Peleska J., Jindra A., Jachymova M., Kvasnicka J., Horky K., Aschermann M. Circulating ICAM-1, endothelin-1 and vWF markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACEI. Journal of Human Hypertension. 16(8):2002;557-562.
14. Inone A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto M.K., Masaki T. The human endothelin family: the structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;2863-2867.
15. John G.W., Gray M.R., Bates D.L., Beacham J.L. Enzyme immunoassay - a new technique for estimating HbA1c. Clinical Chemistry. 39:1993;663-666.
16. Kannel W.B., Larson M. Long-term epidemiologic prediction of coronary disease. The Framingham experience. Cardiology. 82:1993;137-152.
17. LeFebvre P.J., Scheen A.J. The postprandial state and risk of cardiovascular disease. Diabetic Medicine. 15(Suppl. 4):1998;S63-S68.
18. Matsumoto K., Sera Y., Nakamura H., Ucki Y., Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycaemia and insulin resistance in patients with type 2 diabetes mellitus. DRCP. 55:2002;131-138.
19. Matsumoto K., Sera Y., Abe Y., Ueki Y., Miyake S. Serum concentration of soluble VCAM-1 and e-selectin are elevated in insulin resistant patients with type 2 diabetes. Diabetes Care. 24(9):2001;1697-1698.
20. Mattei P., Virdis A., Ghiadoni L., Taddei S., Salvetti A. Endothelial function in hypertension. Journal of Nephrology. 10:1997;192-197.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.L. Homoestasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
22. Mizia-Steck K., Zahorstra-Markiewicz B., Mandecki T., Janowska J., Szulc A., Jastrzebska-Maj E. Serum levels of selected adhesion molecules in patients with coronary artery disease. International Journal of Cardiology. 83(2):2002;143-150.
23. Morise T., Takeuchi Y., Kawano M., Koni I., Takeda R. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care. 18:1995;87-89.
24. Pepinsky B., Hession C., Chen L.-L., Moy P., Bierkly L., Jakubowsky A., Chow E.P., Benjamin C., Chi-Rosso G., Luhoxskys S., Lobb R. Structure/function studies of VCAM-1. Journal of Biological Chemistry. 267:1992;17820-17826.
25. Ramachandran A., Snehalatha C., Latha E., Vijay V., Viswanathan M. Rising prevalence of NIDDM in urban population in India. Diabetologia. 40:1997;232-237.
26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 362:1993;801-809.
27. Saito Y., Nakao K., Mukoyama M., Imura H. Increased plasma endothelin levels in patients with essential hypertension. Letter New England Journal of Medicine. 322:1990;205.
28. Snehalatha C., Ramachandran A., Satyavani K., Vijay V., Haffner S.M. Specific insulin and proinsulin concentration in non-diabetic South Indians. Metabolism. 47:1998;230-233.
29. Snehalatha C., Ramachandran A., Vijay V., Viswanathan M. Differences in plasma insulin responses in urban and rural Indians: a study in Southern-Indians. Diabetic Medicine. 11:1994;445-448.
30. Sorensen K.E., Celermajer D.S., Georgakopoulos D., Hatcher G., Betteridge D.J., Deanfield J.E. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the lipoprotein (a) level. Journal of Clinical Investigation. 93:1994;50-55.
31. Stad R.K., Buurman W.A. Current views on structure and function of endothelial adhesion molecules. Cell Adhesion and Communication. 2:1994;261-268.
32. Stauton D.E., Marlin S.D., Stratowa C., Dustin M.L., Springer T.A. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 52:1988;925-933.
33. Takahashi K., Ghatei M.A., Lam H.C., O'Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1992;306-310.
34. Varley H., Gowenlock A.H., Bell M. Practical clinical biochemistry, 5th ed. vol. 1:1980;388-400 Willian Heinmann Medical Books, Great Britain.
35. Wang L., Yu Z., Mao T. Relationship between elevated plasma endothelin-1 level and renal function in patients with diabetic nephropathy. Zhonghua Neike Zazhi. 5:1995;318-321.
36. Yanagisawa M., Kurihara H., Kimura S., Tomotx Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor by vascular EC. Nature. 332:1988;411-451.
37. Yudkin J.S., Forrest R.D., Jackson C.A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet. ii:1988;530-533.